Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (4): 515-520    DOI: 10.12891/ceog3369.2017
Original Research Previous articles | Next articles
Clinical screening method and risk factors’ analysis of congenital cardiovascular defects: a case control study from a Chinese local region
F.Q. Ma1, G.Y. Zhang1, J.B. Gao1, C. Fang1, Y. Bo1, G.Y. Huang2, A.H. Zhang1, *()
1 Department of Cardiac Surgery, Maternal and Child Health Hospital of Taian, Taian, China
2 The Children's Hospital of Fudan University, Shanghai, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  Aim: To explore the effective clinical screening method and risk factors of congenital heart disease (CHD) in neonates. Materials and Methods: The authors screened neonatal congenital heart diseases using eight clinical screening indexes and analyzed to acquire the simplest and most effective screening method. They also conducted a hospital-based 1:1 matched case (total 64 cases) – control study to analyze a series of underlying risk factors. Result: The eight clinical indexes are reliable screening means. The main risk factors influencing the incidence of CHD in the present samples were abnormal reproductive history (p = 0.008), negative stimulus (p = 0.075), upper respiratory infection (p = 0.06), diabetes mellitus (p = 0.058), high blood pressure (p = 0.041), husband's cigarette smoking (p = 0.001), and gravidity (p = 0.000). Conclusion: The eight clinical indexes were reliable means to screen CHD in neonates. Eliminating abortion or other abnormal reproduction, augmenting maternal mental healthcare, preventing upper respiratory tract infections, limiting medication during early pregnancy including antihypertensive agent, controlling blood glucose levels, and abstaining from cigarette may lower the occurrence of CHD.
Key words:  Congenital heart disease      Risk factors      Case control study     
Published:  10 August 2017     
*Corresponding Author(s):  A.H. ZHANG     E-mail:  18253166102@163.com

Cite this article: 

F.Q. Ma, G.Y. Zhang, J.B. Gao, C. Fang, Y. Bo, G.Y. Huang, A.H. Zhang. Clinical screening method and risk factors’ analysis of congenital cardiovascular defects: a case control study from a Chinese local region. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 515-520.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3369.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I4/515

[1] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[2] Li Li Zhang, Hua Shu, Shuai Zhang, Tian Tian Wang, Lan Lan Zhang. Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 189-193.
[3] T. T. Kitova, B. D. Kitov, E. H. Uchikova, N. T. Ahmad. Maternal age - a risk factor for congenital hydrocephalus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 257-261.
[4] Qianhong Liang, Wei Gong, Dongming Zheng, Risheng Zhong, Yunjie Wen, Xiaodan Wang. Preliminary analysis of risk factors for congenital heart disease: a retrospective review of 145 cases in a single institution[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 713-722.
[5] S.M.S. Fernandes, J.C.L. Ribalta, N.M.G. Speck, Y. Yamamura. Treatment of uterine cervical ectopy with acupuncture and analysis of risk factors in the metaplastic process[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 601-605.
[6] M. Li, L. Riming, W. Zhe, W. Hong, H. Xiaofei, C. Lina, Z. Zhengfang, W. Xuebo, W. Ning, S. Chengming, H. Qing-qing, L. Hailiang, W. Hui. Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 523-528.
No Suggested Reading articles found!